A comprehensive literature review reported that factors associated with an increased RR in HER2-positive early BC include lymph node positivity, higher BMI, residual disease after neoadjuvant therapy, low expression of Ki-67, low levels of TILs, younger age at diagnosis, HR positivity, and large tumor size [57]. This evidence concerns the gene MKI67 and breast cancer.